LyphoMed, Inc. v. Superior Court

837 P.2d 1158, 172 Ariz. 423
CourtCourt of Appeals of Arizona
DecidedMarch 23, 1992
Docket1 CA-SA 91-225
StatusPublished
Cited by12 cases

This text of 837 P.2d 1158 (LyphoMed, Inc. v. Superior Court) is published on Counsel Stack Legal Research, covering Court of Appeals of Arizona primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
LyphoMed, Inc. v. Superior Court, 837 P.2d 1158, 172 Ariz. 423 (Ark. Ct. App. 1992).

Opinion

OPINION

KLEINSCHMIDT, Judge.

We accepted jurisdiction of this special action because it involves a question of the interpretation of a relatively new statute abolishing joint and several liability, and of how the rules of civil procedure relating to that statute are to be applied. When we accepted jurisdiction, we granted the relief the petitioner requested and stated that an opinion would follow. This is that opinion. We conclude that each defendant who claims that other persons or entities who have not been joined in the action are responsible for the plaintiff’s injury must file a notice of nonparty at fault *425 pursuant to Rule 26(b)(5), Arizona Rules of Civil Procedure. A defendant is not relieved of the need to file such a notice simply because another defendant in the case has done so, even though the latter names all of the nonparties at fault the defendant who has not filed a notice would name. Although the petitioner did not comply with the rule as we construe it, we grant relief because we find that the trial court abused its discretion in finding that the petitioner was equitably estopped to give the notice late.

FACTS AND PROCEDURAL HISTORY

The case arises out of the death of a woman allegedly caused by an overdose of medication administered to her when she was a patient at Winslow Memorial Hospital. In May of 1990, the woman’s survivors sued the hospital and the petitioner, LyphoMed, Inc., the manufacturer of the medication. The basis of the claim against LyphoMed is that it mislabeled the medication.

The statute abolishing joint and several liability, Ariz.Rev.Stat.Ann. (“A.R.S.”) § 12-2506 (1987), and Rules 26(b)(5) and 26(e) of the Arizona Rules of Civil Procedure bear on what happened thereafter. The statute provides:

Joint and several liability abolished: exceptions; apportionment of degrees of fault; definitions
A. In an action for personal injury, property damage or wrongful death, the liability of each defendant for damages is several only and is not joint, except as otherwise provided in this section. Each defendant is liable only for the amount of damages allocated to that defendant in direct proportion to that defendant’s percentage of fault, and a separate judgment shall be entered against the defendant for that amount. To determine the amount of judgment to be entered against each defendant, the trier of fact shall multiply the total amount of damages recoverable by the plaintiff by the percentage of each defendant’s fault, and that amount is the maximum recoverable against the defendant.
B. In assessing percentages of fault the trier of fact shall consider the fault of all persons who contributed to the alleged injury, death or damage to property, regardless of whether the person was, or could have been, named as a party to the suit. Negligence or fault of a nonparty may be considered if the plaintiff entered into a settlement agreement with the nonparty or if the defending party gives notice before trial, in accordance with requirements established by court rule, that a nonparty was wholly or partially at fault. Assessments of percentages of fault for nonparties are used only as a vehicle for accurately determining the fault of the named parties. Assessment of fault against nonparties does not subject any nonparty to liability in this or any other action, and it may not be introduced as evidence of liability in any action.

Rule 26(b)(5) of the Arizona Rules of Civil Procedure was adopted to implement the statute. It provides:

(5) Non-Party at Fault. Any party who alleges, pursuant to A.R.S. § 12-2506(B) (as amended), that a person or entity not a party to the action was wholly or partially at fault in causing any personal injury, property damage or wrongful death for which damages are sought in the action shall provide the identity, location, and the facts supporting the claimed liability of such nonparty at the time of compliance with the requirements of Rule V(a) of the Uniform Rules of Practice of the Superior Court, if applicable, or within one hundred fifty (150) days after the filing of that party’s answer, whichever is earlier. The trier of fact shall not be permitted to allocate or apportion any percentage of fault to any nonparty whose identity is not disclosed in accordance with the requirements of this subpart 5 except upon written agreement of the parties or upon motion establishing newly discovered evidence of such nonparty’s liability which could not have been discovered within *426 the time periods for compliance with the requirements of this subpart 5. 1

LyphoMed, through its original attorneys, filed an answer, and then an amended answer, which asserted an affirmative defense alleging that “each of the other parties” named in the action was negligent. It asked that if there were a finding in favor of the plaintiff, that fault be apportioned among “all the parties.” Its co-defendant, the hospital, filed an answer and later filed a timely notice pursuant to Rule 26(b)(5) identifying Thomas E. Brown, M.D., and William N. Foxley, M.D., as nonparties at fault in causing the death of plaintiffs decedent. LyphoMed did not file a timely notice of nonparties at fault.

In January of 1991, the plaintiffs began negotiating with the hospital to settle the case. Both parties considered a type of agreement that would require the hospital to remain as a defendant throughout the trial to minimize any effort that LyphoMed might make to cast the blame on the hospital. According to the hospital’s attorney, a settlement agreement which would require the hospital to remain in the case throughout the trial was against the practice followed by both the hospital and its insurance carrier.

In March 1991, some nine months after it filed its answer, LyphoMed responded to an interrogatory propounded by the plaintiff that asked whether LyphoMed contended that the death was caused in whole or in part by anyone other than LyphoMed, whether such person was named as a defendant or not. LyphoMed answered that it did not. According to Monte Simpson, the attorney who prepared LyphoMed’s answer, this answer was a mistake that resulted from her assumption that the interrogatory related only to nonparties. Two other attorneys for LyphoMed had reviewed the answers to interrogatories. The record is silent as to why, if the answer was indeed a mistake, they did not correct it. Ms. Simpson, without contradiction, also asserted that she had repeatedly advised all counsel that LyphoMed’s primary defense was that the hospital and its staff were responsible for the death.

Ultimately, the plaintiffs’ settlement proposal, which would have required the hospital to remain in the case, was rejected by the hospital, and on April 15, 1991, the hospital offered to settle its liability for $250,000 without the condition that it remain in the case. The plaintiffs countered with an offer to accept $300,000 without the provision that the hospital remain as a defendant.

In the meantime, shortly after the answer to the interrogatory was filed, LyphoMed retained new counsel.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Ronnie McDaniel v. Payson Healthcare
Arizona Supreme Court, 2022
Lane v. Core
Court of Appeals of Arizona, 2021
Day v. Armendt
Court of Appeals of Arizona, 2017
Scottsdale Insurance v. Cendejas
205 P.3d 1128 (Court of Appeals of Arizona, 2009)
Bridgestone/Firestone North America Tire, L.L.C. v. Naranjo
79 P.3d 1206 (Court of Appeals of Arizona, 2003)
Rosner v. Denim & Diamonds, Inc.
937 P.2d 353 (Court of Appeals of Arizona, 1996)
Wester v. Crown Controls Corp.
974 F. Supp. 1284 (D. Arizona, 1996)
Soto v. Brinkerhoff
903 P.2d 641 (Court of Appeals of Arizona, 1995)

Cite This Page — Counsel Stack

Bluebook (online)
837 P.2d 1158, 172 Ariz. 423, Counsel Stack Legal Research, https://law.counselstack.com/opinion/lyphomed-inc-v-superior-court-arizctapp-1992.